论文信息 - RITUXIMAB PLUS HYPERCVAD ALTERNATING WITH HIGH DOSE METHOTREXATE AND CYTARABINE (R-HCVAD-AM) FOR PATIENTS WITH NEWLY DIAGNOSED MANTLE CELL LYMPHOMA (MCL). A MULTICENTER TRIAL FROM GISL - 字舞流文

RITUXIMAB PLUS HYPERCVAD ALTERNATING WITH HIGH DOSE METHOTREXATE AND CYTARABINE (R-HCVAD-AM) FOR PATIENTS WITH NEWLY DIAGNOSED MANTLE CELL LYMPHOMA (MCL). A MULTICENTER TRIAL FROM GISL

F. Angrilli | M. Federico | F. Merli | F. Ilariucci | C. Visco | A. Ambrosetti | S. Galimberti | M. Petrini | S. Luminari | C. Stelitano | I. Capodanno | F. Caracciolo | A. Carella | E. Barbolini | N. Renzo